Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A + T Cells to the Aorta

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 8, 2016, Pages 1496-1506

  Butcher, Matthew J ^a   Waseem, Tayab C ^a   Galkina, Elena V ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

atherosclerosis; cytokines; inflammation; leukocytes; smooth muscle cells

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE; COLLAGEN; COLLAGEN TYPE 1; INTERLEUKIN 17; INTERLEUKIN 17C; T LYMPHOCYTE RECEPTOR; COLLAGEN TYPE I, ALPHA 1 CHAIN; IL17A PROTEIN, MOUSE; IL17C PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; AORTA ROOT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL MIGRATION; CONTROLLED STUDY; EX VIVO STUDY; EXPLANT; FEMALE; FIBROBLAST; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SMOOTH MUSCLE CELL; SUPERNATANT; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; UPREGULATION; WESTERN DIET; ANIMAL; AORTIC DISEASES; ATHEROSCLEROTIC PLAQUE; C57BL MOUSE; CELL CULTURE; DEFICIENCY; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; LIPID DIET; METABOLISM; NEUTROPHIL CHEMOTAXIS; PARACRINE SIGNALING; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; COLLAGEN TYPE I; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLASTS; GENETIC PREDISPOSITION TO DISEASE; INFLAMMATION; INTERLEUKIN-17; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PARACRINE COMMUNICATION; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84976545464     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.307892     Document Type: Article

References (41)

1. Mendis S, Puska P, Norrving B, et al. Global Atlas on Cardiovascular Disease Prevention and Control Published by the World Health Organization in Collaboration With the World Heart Federation and the World Stroke Organization. Geneva: World Health Organization; 2009
2. Libby P, Lichtman AH, Hansson GK. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity. 2013;38:1092-1104. doi: 10. 1016/j. immuni. 2013. 06. 009
3. Butcher M, Galkina E. Current views on the functions of interleukin-17A-producing cells in atherosclerosis. Thromb Haemost. 2011;106:787-795. doi: 10. 1160/TH11-05-0342
4. Butcher MJ, Gjurich BN, Phillips T, Galkina EV. The IL-17A/ IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment. Circ Res. 2012;110:675-687. doi: 10. 1161/ CIRCRESAHA. 111. 261784
5. Danzaki K, Matsui Y, Ikesue M, Ohta D, Ito K, Kanayama M, Kurotaki D, Morimoto J, Iwakura Y, Yagita H, Tsutsui H, Uede T. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2012;32:273-280. doi: 10. 1161/ATVBAHA. 111. 229997
6. Madhur MS, Funt SA, Li L, Vinh A, Chen W, Lob HE, Iwakura Y, Blinder Y, Rahman A, Quyyumi AA, Harrison DG. Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol. 2011;31:1565-1572. doi: 10. 1161/ATVBAHA. 111. 227629
7. Taleb S, Tedgui A, Mallat Z. Interleukin-17: friend or foe in atherosclerosis? Curr Opin Lipidol. 2010;21:404-408. doi: 10. 1097/ MOL. 0b013e32833dc7f9
8. Usui F, Kimura H, Ohshiro T, Tatsumi K, Kawashima A, Nishiyama A, Iwakura Y, Ishibashi S, Takahashi M. Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice. Biochem Biophys Res Commun. 2012;420:72-77. doi: 10. 1016/j. bbrc. 2012. 02. 117
9. Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 2009;9:556-567. doi: 10. 1038/nri2586
10. Pappu R, Ramirez-Carrozzi V, Sambandam A. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology. 2011;134:8-16. doi: 10. 1111/j. 1365-2567. 2011. 03465. x
11. Chang SH, Reynolds JM, Pappu BP, Chen G, Martinez GJ, Dong C. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity. 2011;35:611-621. doi: 10. 1016/j. immuni. 2011. 09. 010
12. Song X, Zhu S, Shi P, Liu Y, Shi Y, Levin SD, Qian Y. IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat Immunol. 2011;12:1151-1158. doi: 10. 1038/ni. 2155
13. Ramirez-Carrozzi V, Sambandam A, Luis E, et al. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol. 2011;12:1159-1166. doi: 10. 1038/ni. 2156
14. Johnston A, Fritz Y, Dawes SM, Diaconu D, Al-Attar PM, Guzman AM, Chen CS, Fu W, Gudjonsson JE, McCormick TS, Ward NL. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation. J Immunol. 2013;190:2252-2262. doi: 10. 4049/jimmunol. 1201505
15. Kusagaya H, Fujisawa T, Yamanaka K, Mori K, Hashimoto D, Enomoto N, Inui N, Nakamura Y, Wu R, Maekawa M, Suda T, Chida K. Toll-like receptor-mediated airway IL-17C enhances epithelial host defense in an autocrine/paracrine manner. Am J Respir Cell Mol Biol. 2014;50:30-39. doi: 10. 1165/rcmb. 2013-0130OC
16. Reynolds JM, Martinez GJ, Nallaparaju KC, Chang SH, Wang YH, Dong C. Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C. J Immunol. 2012;189:4226-4230. doi: 10. 4049/ jimmunol. 1103014
17. Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, Krueger JG, Russell CB. The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol. 2013;133:17-26. doi: 10. 1038/jid. 2012. 194
18. Smith E, Prasad KM, Butcher M, Dobrian A, Kolls JK, Ley K, Galkina E. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2010;121:1746-1755. doi: 10. 1161/ CIRCULATIONAHA. 109. 924886
19. Reynolds JM, Angkasekwinai P, Dong C. IL-17 family member cytokines: regulation and function in innate immunity. Cytokine Growth Factor Rev. 2010;21:413-423. doi: 10. 1016/j. cytogfr. 2010. 10. 002
20. Erbel C, Chen L, Bea F, Wangler S, Celik S, Lasitschka F, Wang Y, Böckler D, Katus HA, Dengler TJ. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J Immunol. 2009;183:8167-8175. doi: 10. 4049/jimmunol. 0901126
21. Taleb S, Romain M, Ramkhelawon B, Uyttenhove C, Pasterkamp G, Herbin O, Esposito B, Perez N, Yasukawa H, Van Snick J, Yoshimura A, Tedgui A, Mallat Z. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med. 2009;206:2067-2077. doi: 10. 1084/jem. 20090545
22. van Es T, van Puijvelde GH, Ramos OH, Segers FM, Joosten LA, van den Berg WB, Michon IM, de Vos P, van Berkel TJ, Kuiper J. Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem Biophys Res Commun. 2009;388:261-265. doi: 10. 1016/j. bbrc. 2009. 07. 152
23. Eid RE, Rao DA, Zhou J, Lo SF, Ranjbaran H, Gallo A, Sokol SI, Pfau S, Pober JS, Tellides G. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation. 2009;119:1424-1432. doi: 10. 1161/CIRCULATIONAHA. 108. 827618
24. Erbel C, Dengler TJ, Wangler S, Lasitschka F, Bea F, Wambsganss N, Hakimi M, Böckler D, Katus HA, Gleissner CA. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability. Basic Res Cardiol. 2011;106:125-134. doi: 10. 1007/s00395-010-0135-y
25. Gao Q, Jiang Y, Ma T, Zhu F, Gao F, Zhang P, Guo C, Wang Q, Wang X, Ma C, Zhang Y, Chen W, Zhang L. A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J Immunol. 2010;185:5820-5827. doi: 10. 4049/jimmunol. 1000116
26. Gisterå A, Robertson AK, Andersson J, Ketelhuth DF, Ovchinnikova O, Nilsson SK, Lundberg AM, Li MO, Flavell RA, Hansson GK. Transforming growth factor-β signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway. Sci Transl Med. 2013;5:196ra100. doi: 10. 1126/scitranslmed. 3006133
27. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis (∗). Annu Rev Immunol. 2009;27:165-197. doi: 10. 1146/annurev. immunol. 021908. 132620
28. Cai Y, Kobayashi R, Hashizume-Takizawa T, Kurita-Ochiai T. Porphyromonas gingivalis infection enhances Th17 responses for development of atherosclerosis. Arch Oral Biol. 2014;59:1183-1191. doi: 10. 1016/j. archoralbio. 2014. 07. 012
29. Koltsova EK, Kim G, Lloyd KM, Saris CJ, von Vietinghoff S, Kronenberg M, Ley K. Interleukin-27 receptor limits atherosclerosis in Ldlr-/-mice. Circ Res. 2012;111:1274-1285. doi: 10. 1161/CIRCRESAHA. 112. 277525
30. von Vietinghoff S, Koltsova EK, Mestas J, Diehl CJ, Witztum JL, Ley K. Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation. J Am Coll Cardiol. 2011;57:2194-2204. doi: 10. 1016/j. jacc. 2010. 12. 030
31. Zhang H, Chen J, Liu X, Awar L, McMickle A, Bai F, Nagarajan S, Yu S. IL-17 induces expression of vascular cell adhesion molecule through signalling pathway of NF-κB, but not Akt1 and TAK1 in vascular smooth muscle cells. Scand J Immunol. 2013;77:230-237. doi: 10. 1111/sji. 12030
32. Orr AW, Hastings NE, Blackman BR, Wamhoff BR. Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J Vasc Res. 2010;47:168-180. doi: 10. 1159/000250095
33. Barlic J, Zhang Y, Murphy PM. Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by upregulating chemokine CX3CL1 on smooth muscle cells in a TNFalpha-NFkappaB-dependent manner. J Biol Chem. 2007;282:19167-19176. doi: 10. 1074/jbc. M701642200
34. Hofnagel O, Luechtenborg B, Stolle K, Lorkowski S, Eschert H, Plenz G, Robenek H. Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2004;24:1789-1795. doi: 10. 1161/01. ATV. 0000140061. 89096. 2b
35. Ishibashi M, Sayers S, D'Armiento JM, Tall AR, Welch CL. TLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques. Atherosclerosis. 2013;229:52-61. doi: 10. 1016/j. atherosclerosis. 2013. 03. 035
36. Lee GL, Chang YW, Wu JY, Wu ML, Wu KK, Yet SF, Kuo CC. TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production. Arterioscler Thromb Vasc Biol. 2012;32:2751-2760. doi: 10. 1161/ ATVBAHA. 112. 300302
37. Chen S, Shimada K, Zhang W, Huang G, Crother TR, Arditi M. IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice. J Immunol. 2010;185:5619-5627. doi: 10. 4049/jimmunol. 1001879
38. Griffin GK, Newton G, Tarrio ML, Bu DX, Maganto-Garcia E, Azcutia V, Alcaide P, Grabie N, Luscinskas FW, Croce KJ, Lichtman AH. IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J Immunol. 2012;188:6287-6299. doi: 10. 4049/jimmunol. 1200385
39. Erbel C, Akhavanpoor M, Okuyucu D, et al. IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis. J Immunol. 2014;193:4344-4355. doi: 10. 4049/jimmunol. 1400181
40. Kotla S, Singh NK, Heckle MR, Tigyi GJ, Rao GN. The transcription factor CREB enhances interleukin-17A production and inflammation in a mouse model of atherosclerosis. Sci Signal. 2013;6:ra83. doi: 10. 1126/ scisignal. 2004214
41. Manthey HD, Cochain C, Barnsteiner S, Karshovska E, Pelisek J, Koch M, Chaudhari SM, Busch M, Eckstein HH, Weber C, Koenen RR, Zernecke A. CCR6 selectively promotes monocyte mediated inflammation and atherogenesis in mice. Thromb Haemost. 2013;110:1267-1277. doi: 10. 1160/ TH13-01-0017